Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001062993-24-016169 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-09-01+ | BIO | Last Andrew J. | EVP, COO | M - OptEx | $0.00 | +3,655 | 7,010 | +109% | $0 |
| DM | 2024-09-04 | 2024-09-01+ | BIO | Last Andrew J. | EVP, COO | F - Tax | $337.32 | -1,854 | 7,114 | -21% | -$625.4K |
| DM | 2024-09-04 | 2024-09-01+ | BIO | Last Andrew J. | EVP, COO | M - OptEx | $0.00 | -3,655 | 1,735 | -68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2024-09-02 | M | A | 903 | $0.00 | 8,017.45 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 2 | Common | Bio-Rad A Common Stock | 2024-09-02 | F | D | 458 | $337.32 | 7,559.45 | D | — | — | |
| 3 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 633 | $0.00 | 7,435.45 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 4 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 440 | $337.32 | 6,802.45 | D | — | — | |
| 5 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 867 | $0.00 | 7,242.45 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 6 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 635 | $337.32 | 6,375.45 | D | — | — | |
| 7 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 1,252 | $0.00 | 7,010.45 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 38.5620 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2024. |
| 8 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 321 | $337.32 | 7,114.45 | D | — | — | |
| 9 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 1,252 | $0.00 | 3,756 | D | $0.00 · — to — | 1,252 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On September 1, 2023, the reporting person was granted 5,008 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 10 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 633 | $0.00 | 633 | D | $0.00 · — to — | 633 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 11 | Derivative | Restricted Stock Units | 2024-09-02 | M | D | 903 | $0.00 | 0 | D | $0.00 · — to — | 903 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 12 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 867 | $0.00 | 1,735 | D | $0.00 · — to — | 867 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2022, the reporting person was granted 3,469 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |